Suppr超能文献

经肝门静脉肝内分支插管用于离体肝切除和自体肝移植:灌注肝脏新方法的两例报告

Transhepatic-intrahepatic branches of the portal vein catheterization for ex vivo liver resection and autotransplantation: Two case reports of novel approach to perfuse the liver.

作者信息

Kong Junjie, Shen Shu, Yang Xianwei, Wang Wentao

机构信息

Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, PR China.

出版信息

Medicine (Baltimore). 2019 Mar;98(11):e14706. doi: 10.1097/MD.0000000000014706.

Abstract

RATIONALE

There has been increased use of ex vivo liver resection and autotransplantation (ERAT) for treatment of end-stage hepatic alveolar echinococcosis (HAE). Rapid perfusion of the autograft in bench resection is always required to reduce the warm ischemia time (WIT) and to protect the function of the remnant liver. Nevertheless, the severe invasion of the portal hepatis sometimes makes it impossible to find a usable inflow rapidly and the process of perfusion could be delayed.

PATIENT CONCERNS

Two patients diagnosed with end-stage HAE combined with severe portal hepatis invasion were selected to undergo ERAT at our center.

DIAGNOSIS

Besides the large HAE lesions, the CT imaging of patient 1 showed that part of the intra- and extrahepatic portal vein (PV) had disappeared. Patient 2 had severe invasion of both of the right and left branches of the PV.

INTERVENTIONS

We introduced a new approach for perfusing the liver in ERAT using transhepatic-intrahepatic branches of the PV catheterization. Afterward, ERAT was successfully performed.

OUTCOMES

For patient 1, the WIT was 2 minutes and the cold ischemia time (CIT) was 296 minutes. For patient 2, the WIT was 2 minutes and the CIT was 374 minutes. Patient 1 suffered stenosis of the common bile duct on postoperative day 14, and patient 2 recovered uneventfully. Both of the 2 patients were discharged from the hospital with normal laboratory values on postoperative day 31 and 15, respectively. The laboratory values for both patients at recent follow-up were normal.

LESSONS

Transhepatic-intrahepatic branches of the PV catheterization is useful for decreasing WIT and facilitating the management of ERAT. It is a useful technical variant that could be used in ERAT for treating patients with severe portal hepatis invasion.

摘要

原理

离体肝切除及自体肝移植(ERAT)治疗终末期肝泡型包虫病(HAE)的应用有所增加。在离体切除过程中,始终需要对自体肝进行快速灌注,以减少热缺血时间(WIT)并保护残余肝脏的功能。然而,肝门的严重侵犯有时使得无法迅速找到可用的流入血管,灌注过程可能会延迟。

患者情况

选择两名诊断为终末期HAE并伴有严重肝门侵犯的患者在本中心接受ERAT治疗。

诊断

除了巨大的HAE病灶外,患者1的CT成像显示部分肝内和肝外门静脉(PV)消失。患者2的PV左右分支均受到严重侵犯。

干预措施

我们引入了一种新的方法,即通过经肝-肝内分支PV插管对ERAT中的肝脏进行灌注。随后,成功实施了ERAT。

结果

患者1的WIT为2分钟,冷缺血时间(CIT)为296分钟。患者2的WIT为2分钟,CIT为374分钟。患者1在术后第14天出现胆总管狭窄,患者2恢复顺利。两名患者分别在术后第31天和第15天出院,实验室检查值均正常。近期随访时两名患者的实验室检查值均正常。

经验教训

经肝-肝内分支PV插管有助于减少WIT并便于ERAT的实施。它是一种有用的技术变体,可用于ERAT治疗严重肝门侵犯的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17dc/6426561/fada2b2dfaba/medi-98-e14706-g001.jpg

相似文献

2
Current status of ex-vivo liver resection and autologous liver transplantation for end-stage hepatic alveolar echinococcosis.
Ann Palliat Med. 2020 Jul;9(4):2271-2278. doi: 10.21037/apm-20-184. Epub 2020 Jun 12.
6
Remnant Liver-to-Standard Liver Volume Ratio Below 40% is Safe in Ex Vivo Liver Resection and Autotransplantation.
J Gastrointest Surg. 2019 Oct;23(10):1964-1972. doi: 10.1007/s11605-018-4022-4. Epub 2018 Oct 29.
7
Ex vivo liver resection and autotransplantation versus allotransplantation for end-stage hepatic alveolar echinococcosis.
Int J Infect Dis. 2019 Feb;79:87-93. doi: 10.1016/j.ijid.2018.11.016. Epub 2018 Nov 26.
8
10
Outcomes of different surgical resection techniques for end-stage hepatic alveolar echinococcosis with inferior vena cava invasion.
HPB (Oxford). 2019 Sep;21(9):1219-1229. doi: 10.1016/j.hpb.2018.10.023. Epub 2019 Feb 16.

引用本文的文献

1
A Narrative Review of the Applications of Ex-vivo Human Liver Perfusion.
Cureus. 2023 Feb 9;15(2):e34804. doi: 10.7759/cureus.34804. eCollection 2023 Feb.
3
Molecular principles of metastasis: a hallmark of cancer revisited.
Signal Transduct Target Ther. 2020 Mar 12;5(1):28. doi: 10.1038/s41392-020-0134-x.

本文引用的文献

3
Ex Vivo Liver Resection and Autotransplantation for End-Stage Alveolar Echinococcosis: A Case Series.
Am J Transplant. 2016 Feb;16(2):615-24. doi: 10.1111/ajt.13465. Epub 2015 Oct 13.
5
Review article: portal vein obstruction--epidemiology, pathogenesis, natural history, prognosis and treatment.
Aliment Pharmacol Ther. 2015 Feb;41(3):276-92. doi: 10.1111/apt.13019. Epub 2014 Dec 4.
6
7
Living donor liver transplantation for alveolar echinococcus is a difficult procedure.
Transplant Proc. 2013 Apr;45(3):1028-30. doi: 10.1016/j.transproceed.2013.02.084.
8
Blood transfusion requirement during liver transplantation is an important risk factor for mortality.
J Am Coll Surg. 2013 May;216(5):902-7. doi: 10.1016/j.jamcollsurg.2012.12.047. Epub 2013 Mar 9.
9
Transumbilical portal venous catheterization: a useful adjunct in left lobe living donor liver transplantation.
Clin Transplant. 2012 Nov-Dec;26(6):816-9. doi: 10.1111/j.1399-0012.2012.01663.x. Epub 2012 May 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验